Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 5, 1999, Pages 436-445

  Naitoh, Akira ^a   Aoyagi, Yutaka ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Alpha 1 antitrypsin; Alpha fetoprotein; Fucosylation; Hepatocellular carcinoma; Lens culinaris agglutinin; Transferrin

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; GLYCOPROTEIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FUCOSYLATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033032804     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01882.x     Document Type: Article

References (28)

1. 1 Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull. World Health Org. 1984; 62: 163-83.
2. 2 Okuda K. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Cancer 1980; 45: 2663-9.
3. 3 Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: Review of experimental and clinical data. Cancer Res. 1968; 28: 1344-50.
4. 4 O'Conor GI, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 1970; 25: 1091-8.
5. 5 Karvountzis GG, Redeker AG. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Intern. Med. 1974; 80: 156-60.
6. 6 Chen D-S, Sung J-L. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977; 40: 779-83.
7. 7 Alpert E, Feller ER. Alpha-fetoprotein (AFP) in benign liver diseases. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology 1978; 74: 856-8.
8. 8 Aoyagi Y, Suzuki Y, Isemura M et al. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann Monog. Can. Res. 1984; 75: 809-15.
9. 9 Aoyagi Y, Suzuki Y, Isemura M et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988; 61: 769-74.
10. 10 Aoyagi Y, Suzuki Y, Igarashi K et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: Presence of fucosylated and non-fucosylated triantennary glycans. Br. J. Cancer 1993; 67: 486-92.
11. 11 Aoyagi Y, Isemura M, Suzuki Y et al. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma. Lancet 1985; ii: 1353-4.
12. 12 Aoyagi Y, Suzuki Y, Igarashi K et al. The usefulness of the simultaneous determination of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 1991; 67: 2390-4.
13. 13 Breborowicz J, Mackiewicz A, Breborowicz D. Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand. J. Immunol. 1981; 14: 15-20.
14. 14 Taketa K, Sekiya C, Namiki M et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990; 99: 508-18.
15. 15 Sekine C, Aoyagi Y, Suzuki Y, Ichida F. The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin and its usefulness in the diagnosis of neoplastic diseases of the liver. Br. J. Cancer 1987; 56: 371-5.
16. 16 Saitoh A, Aoyagi Y, Asakura H. Structural analysis on the sugar chains of alpha-1-antitrypsin: Presence of fucosylated biantennary glycan in hepatocellular carcinoma. Arch. Biochem. Biophys. 1993; 303: 281-7.
17. 17 Suzuki Y, Aoyagi Y, Mori S, Suda T, Yanagi M, Asakura H. Microheterogeneity of serum transferrin in the diagnosis of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1996; 11: 358-65.
18. 18 Laemmli UK. Cleavage of the structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
19. 19 Hase S, Ibuki T, Ikenaka T. Re-examination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J. Biochem. 1984; 95: 197-203.
20. 20 Yamamoto S, Hase S, Fukuda S, Sano O, Ikenaka T. Structures of the sugar chain of interferon-γ produced by human myelomonocyte cell line HBL-38. J. Biochem. 1989; 105: 547-55.
21. 21 Tomiya N, Awaya J, Kurono M, Endo S, Arata T, Takahashi N. Analysis of N-linked oligosaccharides using a two-dimensional mapping technique. Anal. Biochem. 1988; 171: 73-90.
22. 22 Pucci P, Siciliano R, Malorni A et al. Human alpha-fetoprotein primary structure: A mass spectrometric study. Biochemistry 1990; 30: 5061-6.
23. 23 Spik G, Debruyne V, Montreuil J, Halbeek H, Vliegenthart JFG. Primary structure of two sialylated triantennary glycans from human serotransferrin. FEBS Lett. 1985; 183: 65-9.
24. 24 MacGillivray RTA, Mendez E, Shewale JG, Sinha SK, Line-back-Zins J, Brew K. The primary structure of human transferrin, the structures of seven cyanogen bromide fragments and the assembly of the complete structure. J. Biol. Chem. 1983; 258: 3543-53.
25. 25 Saitoh A, Aoyagi Y, Mori S et al. Measurement of the fucosylated sugar chains of serum alpha-1-antitrypsin: The relationship between reactivity with Lens culinaris agglutinin and HPLC analysis of the pyridylaminated sugar chains. Acta Med. Biol. 1997; 45: 11-14.
26. 26 Aoyagi Y, Isemura M, Suzuki Y et al. Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells. Lancet 1986; i: 210.
27. 27 Aoyagi Y, Saitoh A, Suzuki Y et al. Fucosylation index of alpha-fetoprotein, a possible aid in early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1993; 17: 50-2.
28. 28 Seta N, Gayno S, Jezequel-Cuer M, Toueg ML, Erlinger S, Durand G. Sequential study of serum glycoprotein fucosylation in acute hepatitis. J. Hepathol. 1997; 26: 265-71.